BioDelivery Sciences International, Inc. (NASDAQ: BDSI) Starts Presentation at the 2017 Disruptive Growth Company Showcase
BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine. The company utilizes its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology as well as other drug delivery technologies to develop and commercialize new applications of proven therapies aimed at addressing important unmet medical needs. The company also works in partnership with third parties to develop and commercialize these products. Current marketed products and products in development address serious and debilitating conditions such as breakthrough cancer pain, chronic pain and opioid dependence. BDSI's headquarters is in Raleigh, North Carolina.…